News – Page 31 – Endpoints News

Sixteen-year-old dies after receiving Sarepta’s Duchenne gene therapy

2 months ago

Exclusive: Foodsmart names former Amwell executive as its new CEO

2 months ago

A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M

2 months ago

Updated: Novartis revamps cardiovascular commercial strategy as Entresto patent cliff looms

2 months ago

CRISPR company Arbor raises $73.9M to test therapy in clinical trials

2 months ago

Sofinnova Partners lands €165M, backed by big pharma, to build early-stage biotechs in Europe

2 months ago

FDA staff return to White Oak campus en masse after Trump administration push

2 months ago

Trump’s HHS defends Biden-era stance on 340B rebate models

2 months ago

AstraZeneca taps Alteogen in deal worth more than $1.3B to make subcutaneous cancer drugs

2 months ago

WuXi AppTec's US revenue growth continues to dip in post-Biosecure environment

2 months ago

AstraZeneca reports Phase 3 success for rare disease drug at heart of Amolyt deal

2 months ago

All selected drugmakers agree to second round of price negotiations under the IRA

2 months ago

Incyte's stock sinks as pivotal skin disease data disappoint

2 months ago

Orca Bio's T cell therapy may help blood cancer patients avoid transplant issues

2 months ago

Vertanical’s Phase 3 win for non-opioid painkiller; Apriori lays off 40% of staff

2 months ago

Post-Hoc: Kennedy's anti-vaccine actions shouldn't surprise anyone

2 months ago

George Church spinout developing genomically recoded organisms cuts most employees

2 months ago

Curevo gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on board

2 months ago

Otsuka's Taiho buys Swiss startup Araris with three ADCs nearing the clinic

2 months ago

AstraZeneca spotlights first-in-human data for B7-H4-targeting ADC in endometrial cancer

2 months ago

HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts down

2 months ago

Avidity seeks to 'set the standard' as it heads to FDA with Duchenne drug

2 months ago

AstraZeneca to buy cell therapy startup for $425M upfront

2 months ago

Latigo collects $150M to get non-opioid data to compete with Vertex in acute pain

2 months ago

First page Previous page 28 29 303132 33 34 Next page Last page